Franklin Resources’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$280K Buy
+8,287
New +$235K ﹤0.01% 2679
2025
Q3
Sell
-50,108
Closed -$1.67M 3132
2025
Q2
$1.67M Sell
50,108
-17,964
-26% -$544K ﹤0.01% 1777
2025
Q1
$1.99M Buy
68,072
+1,611
+2% +$53.4K ﹤0.01% 1692
2024
Q4
$2.18M Buy
66,461
+30,144
+83% +$1.42M ﹤0.01% 1707
2024
Q3
$1.5M Buy
+36,317
New +$1.65M ﹤0.01% 1827
2023
Q3
Sell
-10,021
Closed -$284K 2661
2023
Q2
$284K Buy
10,021
+41
+0.4% +$1.02K ﹤0.01% 2233
2023
Q1
$229K Sell
9,980
-93
-0.9% -$2.47K ﹤0.01% 1961
2022
Q4
$283K Buy
10,073
+2,003
+25% +$56.4K ﹤0.01% 1886
2022
Q3
$229K Buy
+8,070
New +$216K ﹤0.01% 1950
2019
Q1
Sell
-101,700
Closed -$4.69M 1484
2018
Q4
$4.69M Buy
101,700
+44,300
+77% +$2.73M ﹤0.01% 1005
2018
Q3
$4.43M Hold
57,400
﹤0.01% 1076
2018
Q2
$4.83M Hold
57,400
﹤0.01% 1047
2018
Q1
$4.69M Sell
57,400
-5,100
-8% -$394K ﹤0.01% 1051
2017
Q4
$3.57M Sell
62,500
-2,500
-4% -$157K ﹤0.01% 1128
2017
Q3
$4.34M Buy
+65,000
New +$3.9M ﹤0.01% 1085
2014
Q4
Sell
-358,600
Closed -$22M 1569
2014
Q3
$22M Sell
358,600
-77,900
-18% -$3.36M 0.01% 845
2014
Q2
$20M Sell
436,500
-41,800
-9% -$1.7M 0.01% 873
2014
Q1
$18.7M Sell
478,300
-23,200
-5% -$776K 0.01% 872
2013
Q4
$12M Sell
501,500
-127,900
-20% -$2.91M 0.01% 943
2013
Q3
$17.6M Buy
+629,400
New +$17.4M 0.01% 839

Other funds holding AGIO

Franklin Resources's AGIO Position: Q1 2026 in Review

Franklin Resources opened a new position in Agios Pharmaceuticals (AGIO) in Q1 2026: 8,287 shares worth $280K. The stake represents ﹤0.01% of the portfolio and ranks #2679 among its holdings. This is a return to the name: Franklin Resources previously reported a position in AGIO as recently as Q2 2025.

Franklin Resources first reported a position in AGIO in Q3 2013 and has held it in 20 quarters since. The position peaked at $22M in Q3 2014. 232 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • Franklin Resources held 8,287 shares of Agios Pharmaceuticals worth $280K as of Q1 2026.
  • Agios Pharmaceuticals was a new Franklin Resources position in Q1 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of Franklin Resources's portfolio in Q1 2026, its #2679 holding.
  • Franklin Resources first reported a position in Agios Pharmaceuticals in Q3 2013 and has held it in 20 quarters since.
  • Franklin Resources's Agios Pharmaceuticals position peaked at $22M in Q3 2014.
  • 232 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.